Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I

BACKGROUND: Chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphatic leukemia (Ph + ALL) are caused by the t(9;22), which fuses BCR to ABL resulting in deregulated ABL-tyrosine kinase activity. The constitutively activated BCR/ABL-kinase “escapes” the auto-inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mian, Afsar Ali, Metodieva, Anna, Badura, Susanne, Khateb, Mamduh, Ruimi, Nili, Najajreh, Yousef, Ottmann, Oliver Gerhard, Mahajna, Jamal, Ruthardt, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488316/
https://www.ncbi.nlm.nih.gov/pubmed/22985168
http://dx.doi.org/10.1186/1471-2407-12-411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488316/
https://www.ncbi.nlm.nih.gov/pubmed/22985168
http://dx.doi.org/10.1186/1471-2407-12-411

Ejemplares similares